Bausch Health Companies Inc. (BHC.TO)
CAD 10.59
(-3.73%)
CAD 10.59
(-3.73%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -592 Million USD | -179.25% |
| 2022 | -212 Million USD | 77.37% |
| 2021 | -937 Million USD | -67.62% |
| 2020 | -559 Million USD | 68.65% |
| 2019 | -1.78 Billion USD | 57.02% |
| 2018 | -4.14 Billion USD | -272.55% |
| 2017 | 2.4 Billion USD | 199.79% |
| 2016 | -2.4 Billion USD | -804.96% |
| 2015 | -266.2 Million USD | -129.14% |
| 2014 | 913.5 Million USD | 205.47% |
| 2013 | -866.14 Million USD | -646.51% |
| 2012 | -116.02 Million USD | -172.72% |
| 2011 | 159.55 Million USD | 176.64% |
| 2010 | -208.19 Million USD | -217.99% |
| 2009 | 176.45 Million USD | -11.73% |
| 2008 | 199.9 Million USD | 2.23% |
| 2007 | 195.53 Million USD | -4.12% |
| 2006 | 203.93 Million USD | 129.07% |
| 2005 | 89.02 Million USD | 68.78% |
| 2004 | 52.74 Million USD | 293.46% |
| 2003 | -27.26 Million USD | -131.06% |
| 2002 | 87.79 Million USD | 0.4% |
| 2001 | 87.44 Million USD | 159.1% |
| 2000 | -147.97 Million USD | -336.76% |
| 1999 | 62.5 Million USD | 37.67% |
| 1998 | 45.4 Million USD | 28.98% |
| 1997 | 35.2 Million USD | 55.07% |
| 1996 | 22.7 Million USD | 284.75% |
| 1995 | 5.9 Million USD | -37.89% |
| 1994 | 9.5 Million USD | 143.59% |
| 1993 | 3.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -64 Million USD | -64.1% |
| 2024 Q2 | 10 Million USD | 115.63% |
| 2023 Q3 | -378 Million USD | -1553.85% |
| 2023 Q1 | -209 Million USD | 49.02% |
| 2023 FY | -592 Million USD | -179.25% |
| 2023 Q2 | 26 Million USD | 112.44% |
| 2023 Q4 | -39 Million USD | 89.68% |
| 2022 FY | -212 Million USD | 77.37% |
| 2022 Q1 | -66 Million USD | -195.65% |
| 2022 Q2 | -139 Million USD | -110.61% |
| 2022 Q3 | 399 Million USD | 387.05% |
| 2022 Q4 | -410 Million USD | -202.76% |
| 2021 FY | -937 Million USD | -67.62% |
| 2021 Q2 | -595 Million USD | 2.46% |
| 2021 Q3 | 188 Million USD | 131.6% |
| 2021 Q4 | 69 Million USD | -63.3% |
| 2021 Q1 | -610 Million USD | -298.69% |
| 2020 FY | -559 Million USD | 68.65% |
| 2020 Q2 | -326 Million USD | -114.47% |
| 2020 Q3 | 71 Million USD | 121.78% |
| 2020 Q4 | -153 Million USD | -315.49% |
| 2020 Q1 | -152 Million USD | 89.97% |
| 2019 Q4 | -1.51 Billion USD | -2993.88% |
| 2019 FY | -1.78 Billion USD | 57.02% |
| 2019 Q1 | -52 Million USD | 84.88% |
| 2019 Q2 | -171 Million USD | -228.85% |
| 2019 Q3 | -49 Million USD | 71.35% |
| 2018 Q2 | -873 Million USD | 67.58% |
| 2018 Q1 | -2.69 Billion USD | -624.95% |
| 2018 FY | -4.14 Billion USD | -272.55% |
| 2018 Q4 | -344 Million USD | 1.71% |
| 2018 Q3 | -350 Million USD | 59.91% |
| 2017 FY | 2.4 Billion USD | 199.79% |
| 2017 Q2 | -38 Million USD | -106.05% |
| 2017 Q1 | 628 Million USD | 221.94% |
| 2017 Q3 | 1.3 Billion USD | 3523.68% |
| 2017 Q4 | 513 Million USD | -60.57% |
| 2016 Q1 | -373.7 Million USD | -11.09% |
| 2016 Q3 | -1.21 Billion USD | -303.04% |
| 2016 FY | -2.4 Billion USD | -804.96% |
| 2016 Q4 | -515 Million USD | 57.73% |
| 2016 Q2 | -302.3 Million USD | 19.11% |
| 2015 Q4 | -336.4 Million USD | -779.6% |
| 2015 Q3 | 49.5 Million USD | 193.4% |
| 2015 Q2 | -53 Million USD | -171.91% |
| 2015 FY | -266.2 Million USD | -129.14% |
| 2015 Q1 | 73.7 Million USD | -86.22% |
| 2014 FY | 913.5 Million USD | 205.47% |
| 2014 Q4 | 534.9 Million USD | 94.23% |
| 2014 Q3 | 275.4 Million USD | 118.92% |
| 2014 Q2 | 125.8 Million USD | 656.64% |
| 2014 Q1 | -22.6 Million USD | -118.26% |
| 2013 Q2 | 10.86 Million USD | 139.47% |
| 2013 Q3 | -973.24 Million USD | -9056.77% |
| 2013 FY | -866.14 Million USD | -646.51% |
| 2013 Q4 | 123.76 Million USD | 112.72% |
| 2013 Q1 | -27.53 Million USD | 69.12% |
| 2012 Q4 | -89.14 Million USD | -1266.02% |
| 2012 Q2 | -21.6 Million USD | -67.22% |
| 2012 Q3 | 7.64 Million USD | 135.38% |
| 2012 Q1 | -12.92 Million USD | -123.13% |
| 2012 FY | -116.02 Million USD | -172.72% |
| 2011 FY | 159.55 Million USD | 176.64% |
| 2011 Q4 | 55.85 Million USD | 36.69% |
| 2011 Q3 | 40.86 Million USD | -27.5% |
| 2011 Q2 | 56.36 Million USD | 769.48% |
| 2011 Q1 | 6.48 Million USD | 120.82% |
| 2010 Q4 | -31.13 Million USD | 85.03% |
| 2010 FY | -208.19 Million USD | -217.99% |
| 2010 Q3 | -207.88 Million USD | -711.98% |
| 2010 Q2 | 33.96 Million USD | 1178.38% |
| 2010 Q1 | -3.15 Million USD | -104.32% |
| 2009 Q2 | 24.09 Million USD | -38.24% |
| 2009 Q3 | 40.36 Million USD | 67.55% |
| 2009 FY | 176.45 Million USD | -11.73% |
| 2009 Q4 | 73 Million USD | 80.86% |
| 2009 Q1 | 39 Million USD | -67.6% |
| 2008 FY | 199.9 Million USD | 2.23% |
| 2008 Q4 | 120.38 Million USD | 148.53% |
| 2008 Q3 | 48.43 Million USD | 291.53% |
| 2008 Q2 | -25.28 Million USD | -144.86% |
| 2008 Q1 | 56.37 Million USD | 276.33% |
| 2007 FY | 195.53 Million USD | -4.12% |
| 2007 Q4 | -31.97 Million USD | -148.54% |
| 2007 Q1 | 93.81 Million USD | -18.64% |
| 2007 Q2 | 67.82 Million USD | -27.71% |
| 2007 Q3 | 65.86 Million USD | -2.89% |
| 2006 FY | 203.93 Million USD | 129.07% |
| 2006 Q4 | 115.3 Million USD | 304.26% |
| 2006 Q3 | -56.45 Million USD | -170.04% |
| 2006 Q2 | 80.59 Million USD | 24.98% |
| 2006 Q1 | 64.48 Million USD | 334.71% |
| 2005 Q1 | 11.13 Million USD | 117.9% |
| 2005 Q2 | 3.7 Million USD | -66.7% |
| 2005 Q3 | 101.66 Million USD | 2642.46% |
| 2005 FY | 89.02 Million USD | 68.78% |
| 2005 Q4 | -27.47 Million USD | -127.03% |
| 2004 Q2 | 44.2 Million USD | 109.46% |
| 2004 FY | 52.74 Million USD | 293.46% |
| 2004 Q4 | -62.2 Million USD | -225.32% |
| 2004 Q3 | 49.63 Million USD | 12.28% |
| 2004 Q1 | 21.1 Million USD | 120.65% |
| 2003 FY | -27.26 Million USD | -131.06% |
| 2003 Q1 | 62.99 Million USD | 161.28% |
| 2003 Q2 | -1.01 Million USD | -101.61% |
| 2003 Q3 | 12.98 Million USD | 1383.1% |
| 2003 Q4 | -102.22 Million USD | -887.29% |
| 2002 FY | 87.79 Million USD | 0.4% |
| 2002 Q3 | 74.97 Million USD | 19.85% |
| 2002 Q2 | 62.55 Million USD | 17.92% |
| 2002 Q1 | 53.05 Million USD | 380.37% |
| 2002 Q4 | -102.79 Million USD | -237.1% |
| 2001 Q3 | 33.1 Million USD | -24.95% |
| 2001 FY | 87.44 Million USD | 159.1% |
| 2001 Q4 | -18.92 Million USD | -157.16% |
| 2001 Q2 | 44.1 Million USD | 51.21% |
| 2001 Q1 | 29.16 Million USD | 147.99% |
| 2000 Q2 | 22.34 Million USD | 423.89% |
| 2000 Q3 | -102.64 Million USD | -559.44% |
| 2000 Q4 | -60.77 Million USD | 40.8% |
| 2000 Q1 | -6.89 Million USD | -127.59% |
| 2000 FY | -147.97 Million USD | -336.76% |
| 1999 Q1 | 8.3 Million USD | -43.92% |
| 1999 Q4 | 25 Million USD | 46.2% |
| 1999 FY | 62.5 Million USD | 37.67% |
| 1999 Q3 | 17.1 Million USD | 41.32% |
| 1999 Q2 | 12.1 Million USD | 45.78% |
| 1998 FY | 45.4 Million USD | 28.98% |
| 1998 Q4 | 14.8 Million USD | 12.12% |
| 1998 Q3 | 13.2 Million USD | 38.95% |
| 1998 Q2 | 9.5 Million USD | 21.79% |
| 1998 Q1 | 7.8 Million USD | -40.91% |
| 1997 FY | 35.2 Million USD | 55.07% |
| 1997 Q4 | 13.2 Million USD | 40.43% |
| 1997 Q3 | 9.4 Million USD | 32.39% |
| 1997 Q2 | 7.1 Million USD | 26.79% |
| 1997 Q1 | 5.6 Million USD | -5.08% |
| 1996 FY | 22.7 Million USD | 284.75% |
| 1996 Q1 | 4.7 Million USD | 46.88% |
| 1996 Q4 | 5.9 Million USD | -6.35% |
| 1996 Q3 | 6.3 Million USD | 8.62% |
| 1996 Q2 | 5.8 Million USD | 23.4% |
| 1995 Q3 | 1 Million USD | 150.0% |
| 1995 FY | 5.9 Million USD | -37.89% |
| 1995 Q4 | 3.2 Million USD | 220.0% |
| 1995 Q1 | 1.2 Million USD | 200.0% |
| 1995 Q2 | 400 Thousand USD | -66.67% |
| 1994 FY | 9.5 Million USD | 143.59% |
| 1994 Q2 | -2 Million USD | -180.0% |
| 1994 Q3 | 400 Thousand USD | 120.0% |
| 1994 Q1 | 2.5 Million USD | 0.0% |
| 1994 Q4 | 400 Thousand USD | 0.0% |
| 1993 FY | 3.9 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | -753.936% |
| Avicanna Inc. | -8.74 Million CAD | -6671.129% |
| Avant Brands Inc. | -5.07 Million CAD | -11576.529% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | -2004.643% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -29708.661% |
| Knight Therapeutics Inc. | -16.83 Million CAD | -3416.484% |
| MediPharm Labs Corp. | -13.08 Million CAD | -4424.956% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | -157.977% |
| Canopy Growth Corporation | -657.26 Million CAD | 9.93% |
| Willow Biosciences Inc. | -13.02 Million CAD | -4443.71% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | -1230.008% |